MAPT and Alzheimer disease: Poorer cognitive performance and higher t-tau and p-tau levels are seen in AD subjects with low VEGF levels, while better cognitive performance and lower t-tau and p-tau levels occur in AD subjects with high VEGF levels (Figure 3).